Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beta Bionics (BBNX) Current Leases (2023 - 2025)

Historic Current Leases for Beta Bionics (BBNX) over the last 3 years, with Q3 2025 value amounting to $2.0 million.

  • Beta Bionics' Current Leases changed N/A to $2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.0 million, marking a year-over-year change of. This contributed to the annual value of $1.5 million for FY2024, which is 2491.83% up from last year.
  • Latest data reveals that Beta Bionics reported Current Leases of $2.0 million as of Q3 2025.
  • Over the past 5 years, Beta Bionics' Current Leases peaked at $2.0 million during Q3 2025, and registered a low of $1.2 million during Q4 2023.
  • Moreover, its 3-year median value for Current Leases was $1.5 million (2025), whereas its average is $1.6 million.
  • Over the last 5 years, Beta Bionics' Current Leases had its largest YoY gain of 2491.83% in 2024, and its largest YoY loss of 2491.83% in 2024.
  • Beta Bionics' Current Leases (Quarter) stood at $1.2 million in 2023, then grew by 24.92% to $1.5 million in 2024, then rose by 29.5% to $2.0 million in 2025.
  • Its last three reported values are $2.0 million in Q3 2025, $1.5 million for Q2 2025, and $1.5 million during Q1 2025.